BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 6197448)

  • 1. Delineation of Ia:nominal antigen complementary determinants recognized by T cells in studies of gene complementation in response to insulin.
    Lin CC; Hansen TH; Passmore HC; Rosenthal AS; Tse HY; Walsh WD; Kanamori S
    J Immunol; 1984 Jan; 132(1):303-9. PubMed ID: 6197448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope specificity and Ia restriction of T cell responses to insulin in a system of complementing Ir genes: analysis with primed lymph node T cells and a long-term cultured T cell line.
    Spaeth E; RĂ¼de E
    Eur J Immunol; 1983 Sep; 13(9):756-61. PubMed ID: 6193966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
    Tomonari K
    J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recognition of insulin by H-2b mice: the mutation in the I-Ab beta gene of the B6.C-H-2bm12 mouse alters the self-I-A-restricted T cell repertoire.
    Hochman PS; Huber BT
    Eur J Immunol; 1984 Jul; 14(7):610-5. PubMed ID: 6204877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antigen-specific restriction sites on Ia molecules as defined by the bm12 mutation.
    Kanamori S; Walsh WD; Hansen TH; Tse HY
    J Immunol; 1984 Dec; 133(6):2811-4. PubMed ID: 6208261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of B6.C-H-2bm12 to heterologous insulins show no correlation with the putative gene conversion but define Iabm12 as functionally unique.
    Hansen TH; Walsh WD; Rubocki RJ; Kapp JA
    J Mol Cell Immunol; 1986; 2(6):359-68. PubMed ID: 3151061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell responses to select Ia determinants using the I-A mutant mouse strain B6.C-H-2bm12.
    Skelly RR; Pappas F; Koprak S; Ahmed A; Hansen TH
    J Immunol; 1982 Nov; 129(5):2094-7. PubMed ID: 6181160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of the immune response genes for LDH-B and MOPC-173. II. Description of an immune response defect in B10.ASR7.
    Gutmann DH; Niederhuber JE
    J Immunol; 1984 Apr; 132(4):1955-9. PubMed ID: 6199419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of B and T cell responses to Ia antigens. IV. Proliferative T cell clones recognizing E beta and/or E alpha allodeterminants.
    Pierres A; Pierres M
    J Immunol; 1983 Mar; 130(3):1262-7. PubMed ID: 6185575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T cell response to allelic determinants on Igh-1-encoded IgG2a antibodies: dual recognition examined by using antigenic antibodies with binding affinity for Ia molecules.
    Hedrick SM; Schwartz RH
    J Immunol; 1983 Apr; 130(4):1958-66. PubMed ID: 6187829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions.
    Germain RN; Bhattacharya A; Dorf ME; Springer TA
    J Immunol; 1982 Mar; 128(3):1409-13. PubMed ID: 6173436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ia molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation.
    Heber-Katz E; Hansburg D; Schwartz RH
    J Mol Cell Immunol; 1983; 1(1):3-18. PubMed ID: 6101061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
    Milich DR; Louie RE; Chisari FV
    J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ia. W39 in the interaction of antigen-presenting cells with T and B lymphocytes.
    Huber BT; Rosenwasser LJ
    Eur J Immunol; 1982 Jan; 12(1):37-43. PubMed ID: 6460640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypic and fluorometric analysis of the antibodies that distinguish the lesion of the I-A mutant B6.C-H-2bm12.
    Melino MR; Epstein SL; Sachs DH; Hansen TH
    J Immunol; 1983 Jul; 131(1):359-64. PubMed ID: 6190915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ia.W39 expression correlates with a specific Ir function.
    Huber BT; Hansen TH; Skelly RR; Thorley-Lawson DA
    J Immunol; 1982 May; 128(5):2349-52. PubMed ID: 6174629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation.
    Glimcher LH; Schroer JA; Chan C; Shevach EM
    J Immunol; 1983 Dec; 131(6):2868-74. PubMed ID: 6196405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to the p-azobenzenearsonate (ABA)-GAT conjugate. II. Hapten-specific T cells induced with ABA-GAT in GAT responder X nonresponder F1 hybrids are restricted to the nonresponder haplotype.
    Regnier D; Seman M
    J Immunol; 1983 Feb; 130(2):573-8. PubMed ID: 6184398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition among class II major histocompatibility molecules for presentation of tyrosine-azobenzenearsonate occurs in vivo and in vitro.
    Baskar S; Leskowitz S
    Eur J Immunol; 1990 Mar; 20(3):587-93. PubMed ID: 2156709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.